Atlanta Center for Medical Research

Interested in volunteering for a clinical study? Please fill out the following form so that we may determine your eligibility for one of ACMR’s ongoing or upcoming studies.

At least one way to contact you is required:

Clicking submit will place you on ACMR’s email newsletter list. You may unsubscribe any time.


The National Institutes of Health defines intermittent explosive disorder (IED) to be “a chronic disorder involving repeated, sudden episodes of impulsive, aggressive violent behavior or angry verbal outburst in which you react grossly out of proportion to the situation.” Explosive eruptions occur suddenly and usually lasts less than 30 minutes. These outburst case significant distress and negatively impacts relationships at home, work, and school.

Symptoms of IED include:

  • Rage
  • Irritability
  • Increased energy
  • Racing thoughts
  • Tingling
  • Tremors
  • Palpitations
  • Chest tightness
  • Threatening or assaulting people or animals
  • Causing property damage

Treatment generally includes psychotherapy and medication but there is no one treatment that’s best for everyone with IED. Further research into the causes of IED and how to treat it is needed for health care professionals to better personalize treatment for each case.

https://www.nih.gov/news-events/news-releases/intermittent-explosive-disorder-affects-16-million-americans


The Atlanta Center for Medical Research was founded in 1982 by Dr. Robert A. Riesenberg and is now one of the largest and most respected medical research institutions in the country. ACMR’s 150,000-square-foot, state-of-the-art, open-source research facility is a game changer for the medical research world. ACMR’s practices set the standard for medical research, facilitating the availability of safe and effective medicine to people everywhere.

ACMR uses cookies to collect information on how visitors behave on our website. The information we collect will not be linked with a visitor's identity.
By continuing to use our website, you agree to our use of cookies.